跳至主要内容
临床试验/ACTRN12621000029897
ACTRN12621000029897尚未招募未知

Effect of probiotic supplementation on composition of fecal microbiota in children with autism spectrum disorder-a pilot randomized controlled trial

Perth children hospital, Child and Adolescent health services0 个研究点目标入组 40 人开始时间: 2021年1月14日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
2 Years 至 5 Years(—)
性别
All

入选标准

  • (1)Children Age: 2–5 years. (2) Confirmed diagnosis of ASD based on DSM-5 criteria.

排除标准

  • (1) Major congenital anomalies (2) Epilepsy syndromes, significant sensory impairment (e.g., blindness, deafness), neonatal hypoxic ischemic encephalopathy requiring therapeutic cooling (3) Coeliac disease, inflammatory bowel disease (4) Use of probiotics for 4 weeks in the 90 days before enrolment (5) Current or recent (within 4 weeks before enrolment) exposure to antibiotics, chemotherapy or immunosuppressant agents, or laxatives. (6) Prosthetic devices including heart valves (7) Confirmed HIV, Hepatitis B, and/or Hepatitis C. (8) Known allergy to probiotics (9) Special diets(10) Cows’ milk protein allergy, food allergy, or conditions such as atopic dermatitis, or eczema.

研究者

发起方
Perth children hospital, Child and Adolescent health services

相似试验